55,000,000
people worldwide are affected by dementia
and Alzheimer's disease contributes 60-70% of the cases
Source: World Health Organization, 2022
£35 billion
have been spent on dementia
treatments in the UK
Source: Wittenberg, et al., 2019
20%
of the senior European population are forecast to be diagnosed with some form of dementia by 2030
Source: European Federation of Pharmaceutical Industries and Associations, 2019
Alzheimer’s disease
Alzheimer’s is a type of dementia that affects memory, thinking, and behaviour.
What is
Pterostilbene?
Pterostilbene is a biologically active polyphenol, which are a family of naturally-occuring organic compounds often found in foods such as grapes, peanuts, and blueberries.
What are we doing with
Pterostilbene?
Due to pterostilbene’s health benefits stated in literature, we will be genetically engineering E. coli bacteria to produce increased yields of pterostilbene for the treatment of neuroinflammation in early stage Alzheimer’s disease.
